Siemens Healthineers (ETR:SHL) received a €32.30 ($37.56) price objective from JPMorgan Chase & Co. in a research report issued on Thursday, September 26th, Borsen Zeitung reports. The firm presently has a “sell” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential downside of 7.45% from the company’s previous close.
Several other analysts have also recently commented on the stock. Goldman Sachs Group set a €34.00 ($39.53) price objective on shares of Siemens Healthineers and gave the company a “neutral” rating in a research note on Thursday, August 8th. Berenberg Bank set a €42.00 ($48.84) price objective on shares of Siemens Healthineers and gave the company a “buy” rating in a research note on Friday, July 12th. Nord/LB set a €36.00 ($41.86) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research report on Monday, July 29th. HSBC set a €41.00 ($47.67) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research report on Tuesday, August 13th. Finally, Royal Bank of Canada set a €36.00 ($41.86) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company’s stock. Siemens Healthineers currently has an average rating of “Hold” and a consensus target price of €37.93 ($44.10).
Siemens Healthineers stock traded up €0.37 ($0.43) during midday trading on Thursday, hitting €34.90 ($40.58). 603,665 shares of the company’s stock were exchanged. The stock has a market cap of $34.90 billion and a price-to-earnings ratio of 24.42. The firm’s 50 day simple moving average is €35.70 and its 200 day simple moving average is €36.49. The company has a debt-to-equity ratio of 55.12, a quick ratio of 0.87 and a current ratio of 1.30. Siemens Healthineers has a 12-month low of €31.90 ($37.09) and a 12-month high of €39.21 ($45.59).
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Featured Article: Hold Rating
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.